Dian Diagnostics In-licenses Metabolon’s Metabolomics Platform

Zhejiang Dian Diagnostics, one of  China ’s largest chains of independent medical laboratories, has entered into a joint laboratory licensing agreement with Metabolon, a metabolomics company based in  North Carolina . Under the terms of the agreement, Dian will install Metabolon’s proprietary Discovery HD4™ platform in its new, state-of-the-art laboratory in  Hangzhou  and use its extensive market presence to commercialize Metabolon’s metabolomics-based products and services throughout  China . Financial and other terms of the agreement were not disclosed. More details.... Stock Symbol (SHE: 300244) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.